Big Pharma To Invest More On NCD Partnerships Over Next Decade – IFPMA Report

Although Big Pharma is investing more in partnerships related to non-communicable diseases such as cancer and diabetes, gaps remain in tech transfer activities and local solutions in developing nations where NCDs are on the rise.

More from Focus On Asia

More from Scrip